Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD276 ( clone H9Tim4_0028). We employs the HBV (T7-BFP-PAX-BamHI) vector components and the SynExpress system of the introns Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Human
Target
CD276
Clone
H9Tim4_0028
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
BFP
Promoter
T7
Effector Gene
PAX
Insertion Sites
BamHI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.86
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.